FDA approves Pfizer RSV vaccine for older adults

The Food and Drug Administration (FDA) on Wednesday approved Pfizer’s vaccine to prevent the respiratory disease RSV in older adults, the company announced. After decades without any RSV shots, the market is suddenly very competitive. The approval of Pfizer’s Abrysvo marks the second authorized RSV shot for older adults in the U.S. this month, after … Read more

Pfizer’s Paxlovid still free, for now, after FDA grants full approval to COVID drug

The Biden administration will continue to manage the distribution of free courses of Pfizer’s Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the Food and Drug Administration granted Pfizer full approval Thursday to market the pills. “At this time, the U.S. government will continue to oversee the distribution … Read more

Did Mattiedna Johnson Help Cure Scarlet Fever?

Mattiedna Johnson wasn’t a microbiologist by trade – she was a nurse – but that didn’t stop her from helping in the race to develop lifesaving antibiotics. Born in 1918 to Mississippi sharecroppers, Johnson was a high school salutatorian before graduating from nursing school in Memphis, TN, and starting work as a registered nurse. In … Read more

Health Care — Long COVID linked to thousands of US deaths

One Minnesota woman was able to capture the rare phenomenon of thundersnow on camera. Who knew that was a thing? Today in health, the CDC released new research findings linking thousands of deaths to long COVID, highlighting the potential severity of the post-COVID condition that is still not well understood.  Welcome to Overnight Health Care, where we’re … Read more

Pfizer signs deal to sell Paxlovid in China as COVID cases climb: report

Pfizer has inked a deal with a Chinese-based pharmaceutical company to sell the COVID-19 antiviral Paxlovid in the country, according to Bloomberg. The announcement with China Meheco Group, which Bloomberg reported was made in a filing with the Shanghai stock exchange, comes as China faces a surge in coronavirus infections as it eases its “zero … Read more

Amgen in Advanced Talks to Buy Horizon Therapeutics

Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more

The 7 Companies That Do It All Well in the Rankings of Best-Managed Companies

“Managers,” Peter Drucker wrote, “must understand that business results depend on a balance of efforts and results in a number of areas.” Yet if the Drucker Institute’s measure of corporate effectiveness is any indication, that is much easier said than done.

FDA authorizes bivalent COVID-19 boosters for children as young as 6 months

The Food and Drug Administration (FDA) on Thursday announced it has expanded the emergency use authorization for the bivalent COVID-19 booster to include children between the ages of 6 months and 5 years. With this announcement, children older than 6 months who have received the primary two-dose coronavirus vaccines from Moderna are now eligible to … Read more

Half of public say they’re uninformed on new COVID boosters: survey

A new poll released on Friday found that half of U.S. adults say they know little to nothing about the recently authorized bivalent coronavirus booster doses almost one month after they were made available. The data from the Kaiser Family Foundation’s (KFF) COVID-19 Vaccine Monitor found that a minority of people said they knew “a … Read more

Pfizer CEO tests positive for COVID-19 again

Pfizer CEO Albert Bourla said on Saturday that he has tested positive for COVID-19 again — the second time he has contracted the virus in under two months. “While we’ve made great progress, the virus is still with us,” he wrote on Twitter. Bourla, who previously tested positive for COVID-19 in mid-August, said he is currently symptom … Read more